• 首页
  • 报告
  • 资讯
  • 快讯
  • 图表
  • Ai问答
  • 网址导航
首页行业分类生物医药生物2023-04-03-国元证券-华熙生物-2022年报点评:业绩增长符合预期,降本增效费用端有望持续优化
PDF

2023-04-03-国元证券-华熙生物-2022年报点评:业绩增长符合预期,降本增效费用端有望持续优化

宇***鄙3页1.01M

下载文档
/3
全屏查看
2023-04-03-国元证券-华熙生物-2022年报点评:业绩增长符合预期,降本增效费用端有望持续优化
还有 3 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 3 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
国元证券JOYUAN SECURITIES202A20222023E2022021A20222023E2025E384.154023.106034.948348.0311034.894947.77639.198152.1410193.2612304.211806.641606.132736.364478.706330.861035.251463.231985.092599.603327.93448.44551.43840.14营业税金及附加57.6877.2098.96123.74149.3528.9051.9183.21100.442436.173049.373774.444637.935450.788.18171.76233.14305.16390.66302.99392.87601.40676.73709.131161.542039.242605.37284.34388.19611.60733.259546的583.32898.79743.51767.42-0.49-49.17-133.84-208.243519.59-29.83-15.45-13.22-15.72-18.1019.0068.2343.6155.9249.777.39-0.142662.291609.161899.282135.122135.832021.4720.6511.9218.54166816.50457.26475.06475.06475.06475.06905.551135.311469.911850.732272.121424.162216.081379.591200.251082.311.706.124.404.524.758681.7510068.3212217.1414663.5017.056.329.319.608.961400.511644.041831.372402.132920.92890.201135.111465.001855.652267.90139.200.000.0011464174.73219.75278.35340.19816.841028.711811.16775.56961.381245.251577.311927.72802.671109.76-6.789.5-10.13-1397-16.94400.77354.73300.37300.22782.33970.921255.391591.271944.66144.18107.97107.97107.97107.97EBITDA1032.481600.121932.802283.03256.59246.76191.65192.40192.251.632.022.613314.041801.281998.772130.992702.503221.143.4549.2125.118.178109481.09481.09481.092021A202242023E3559.153752.833752.833752833752831673.772408.963664.357200.2787.9328.5328.1925.0420.715699.016633787898.269489.5311434.1919.6226.5922.117503.748681.7510068.3212217.1414563.5021.1324.1129.3026.7622.2178.0776.99745072.952021A2022M2023E2024E15.8115.2715.4015.801276.06635.191258.941565.1216326313.7314.6415.8917717.01775.56961.381245.251577.311927.72ROIC(%28.2621.8426.9634.02127.42177.72179.39205.90219.16-0.49-48.66-49.17-133.84-208.2424.0123.0221.17221221.97-20.65-11.92-16.68-16.5012.7816.889.307.336.15358.58-609.09-49462-34.43-319.332.842.453.303.483.7835.65165.75396.64-33.142.311.742.432622.87-989.85-836.2241.9012.95784.21696.410.000.000.000.750.790.910.921.96123.311231-6.1511.3314.131593157615.51-203.70-16.50-136.5554.206.802.582.002.152.04-71.35-170.16-78.90135.32206.58139.20-13.20.000.001.632.022613314.04144.18-36210.000.002651.320.000.001.090.000.0011.8513.7916.4219.7323.77117.62183.680.000.00-309.03-457.91135.32P/E69.7356.1934.2828.05194.99-341.631130.241742.341852.16P/B9.578.225.754.77EV/EB ITDA50.4841.1932.5722.83请务必阅读正文之后的免责条款部分